Gilead Sciences, Inc. and Dragonfly Therapeutics announced a collaboration designed to advance a number of Dragonfly's novel natural killer (NK) cell engager-based immunotherapies for...
GlobalFoundries Inc. announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), for onsemi's proposed acquisition...
